Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,621.30
+13.30 (0.83%)
Aug 21, 2026, 3:14 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 932.86 billion as of August 21, 2026. Its market cap has increased by 53.49% in one year.
Market Cap
932.86B
Enterprise Value
907.66B
Revenue
349.35B
Ranking
n/a
PE Ratio
25.34
Stock Price
1,621.30
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 932.86B, an increase of 9,613.98%. That is a compound annual growth rate of 20.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 932.86B | 35.77% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.28T |
| Cipla | 1.16T |
| Zydus Lifesciences | 1.12T |
| Mankind Pharma | 984.58B |
| Laurus Labs | 973.64B |
| Glenmark Pharmaceuticals | 654.11B |
| Alkem Laboratories | 645.65B |
| Ipca Laboratories | 484.88B |